Demo Sign up Log In

4D Molecular Therapeutics Inc (FDMT)

Cash Conversion Ratio

0.96×

Quarterly · Period ending: Jun 30, 2026

FDMT Cash Conversion Ratio

Latest reported0.96×period endingJun 30, 2026

Latest reported0.96×period endingJun 30, 2026

FDMT Quarterly Cash Conversion Ratio (1.24× → 0.96×)

Latest values, visible window

High-resolution chart · PNG

FDMT cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

4D Molecular Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	0.9605×
Mar 31, 2026	0.9908×
Dec 31, 2025	1.4394×
Sep 30, 2025	0.8159×
Jun 30, 2025	0.7948×
Mar 31, 2025	1.0087×
Dec 31, 2024	0.9424×
Sep 30, 2024	0.7109×
Jun 30, 2024	0.8752×
Mar 31, 2024	0.9197×
Dec 31, 2023	0.7806×
Sep 30, 2023	0.1537×
Jun 30, 2023	0.7722×
Mar 31, 2023	1.0082×
Dec 31, 2022	0.8513×
Sep 30, 2022	0.8945×
Jun 30, 2022	0.7822×
Mar 31, 2022	1.1376×
Dec 31, 2021	1.0737×
Sep 30, 2021	0.8254×
Jun 30, 2021	2.2324×
Mar 31, 2021	0.9761×
Dec 31, 2020	0.8764×
Sep 30, 2020	1.6625×
Jun 30, 2020	0.415×
Mar 31, 2020	1.1087×
Dec 31, 2019	0.5686×
Sep 30, 2019	0.7149×
Jun 30, 2019	1.1401×
Mar 31, 2019	1.1401×
Dec 31, 2018	2.3393×
Sep 30, 2018	2.3393×
Jun 30, 2018	1.2447×
Mar 31, 2018	1.2447×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.